Microbot Medical (NASDAQ:MBOT) Stock Price Passes Above Two Hundred Day Moving Average – Here’s Why

Microbot Medical Inc. (NASDAQ:MBOT)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.98 and traded as high as $1.01. Microbot Medical shares last traded at $1.00, with a volume of 304,319 shares changing hands.

Microbot Medical Trading Up 0.3 %

The company has a market capitalization of $16.93 million, a price-to-earnings ratio of -1.25 and a beta of 1.62. The company’s 50 day simple moving average is $0.97 and its 200-day simple moving average is $0.98.

Hedge Funds Weigh In On Microbot Medical

A hedge fund recently bought a new stake in Microbot Medical stock. Thoroughbred Financial Services LLC bought a new position in shares of Microbot Medical Inc. (NASDAQ:MBOT) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned about 0.33% of Microbot Medical as of its most recent SEC filing. Institutional investors own 16.30% of the company’s stock.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.